Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Lund – page 11

327 clinical trials in Lund, Sweden across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Lund at a glance
327
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

327 trials in Lund

Open in trial search

Induced labour+1

Recruiting

Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Misoprostol
  • Sponsor:University Of Gothenburg

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Gemtuzumab Ozogamicin and a Drug Combination

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Cytarabine
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Study on Montelukast for Slowing Parkinson's Disease Progression in Patients with Mild to Moderate Symptoms

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Levodopa
  • Sponsor:Karolinska University Hospital

Study on Conditioning Treatments with Busulfan, Clofarabine, and Fludarabine for Children with Acute Myeloid Leukemia Undergoing Stem Cell Transplantation

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Busulfan
  • Sponsor:Vaestra Goetalandsregionen

Study on the Safety of Long-Term Use of Deucrictibant for Treating Hereditary Angioedema Attacks in Patients with C1-Inhibitor Deficiency

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Deucrictibant
  • Sponsor:Pharvaris Netherlands B.V.
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177LU) vipivotide tetraxetan
  • Sponsor:Novartis Pharma AG

Study on the Safety and Effectiveness of Quizartinib for Children with Newly Diagnosed FLT3-ITD Positive AML and Normal NPM1

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Quizartinib Dihydrochloride
  • Sponsor:Prinses Maxima Centrum voor Kinderoncologie B.V.

Study on Triamcinolone Acetonide Injections to Prevent Esophageal Strictures in Children with Esophageal Atresia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Triamcinolone Acetonide
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Study on Dapagliflozin for Reducing Atrial Fibrillation and Kidney Injury in Patients Awaiting Coronary Artery Bypass Surgery

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Region Oerebro Laen

Study on the Effects of Adenosine, Dipyridamole, and Apixaban in Patients with Takotsubo Syndrome

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Adenosine
  • Sponsor:Vaestra Goetalandsregionen

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

Study on Mitotane Alone or with Cisplatin and Etoposide for Patients with High-Risk Adrenocortical Carcinoma After Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Amsterdam UMC Stichting

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Lund

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on chronic coronary syndrome and heart failure prevention, including investigations of hyperemic responses and new combination therapies.

  • Adenosine response studies
  • Heart failure prevention trials
  • Lipoprotein management

Advanced cardiovascular research exploring novel treatment approaches for various cardiac conditions.

02 Oncology Studies

Comprehensive research in multiple cancer types, including melanoma, leukemia, and colorectal cancer, testing innovative therapeutic approaches.

  • Immunotherapy trials
  • Blood cancer treatments
  • Targeted therapy studies

Focus on developing more effective and personalized cancer treatments.

03 Mental Health & Neurology

Groundbreaking research in mental health conditions, including studies of anorexia nervosa and major depressive disorder.

  • Psychedelic therapy research
  • Depression treatment studies
  • Innovative therapeutic approaches

Exploring novel treatment modalities for complex psychiatric conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.